![Emmanuel Petiot](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Emmanuel Petiot
Amministratore Delegato presso Morphochem GmbH
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Thomas D. Szucs | M | 64 |
Biovertis AG
![]() Biovertis AG Pharmaceuticals: MajorHealth Technology Biovertis AG operates as a clinical stage pharmaceutical company. It develops small molecule drugs against proprietary microbial antigens. The firm discovers and develops antimicrobial drugs for infections caused by antibiotic-resistant bacterial pathogens. The company was founded by Erich Felber, Uwe von Ahsen, and Alexander Ullrich von Gabain in 2003 and is headquartered in Vienna, Austria. | - |
Alexandra Goll | M | 68 |
Biovertis AG
![]() Biovertis AG Pharmaceuticals: MajorHealth Technology Biovertis AG operates as a clinical stage pharmaceutical company. It develops small molecule drugs against proprietary microbial antigens. The firm discovers and develops antimicrobial drugs for infections caused by antibiotic-resistant bacterial pathogens. The company was founded by Erich Felber, Uwe von Ahsen, and Alexander Ullrich von Gabain in 2003 and is headquartered in Vienna, Austria. | - |
Thomas Kapsner | M | - |
Biovertis AG
![]() Biovertis AG Pharmaceuticals: MajorHealth Technology Biovertis AG operates as a clinical stage pharmaceutical company. It develops small molecule drugs against proprietary microbial antigens. The firm discovers and develops antimicrobial drugs for infections caused by antibiotic-resistant bacterial pathogens. The company was founded by Erich Felber, Uwe von Ahsen, and Alexander Ullrich von Gabain in 2003 and is headquartered in Vienna, Austria. | 18 anni |
Julien Coste | M | - |
Biovertis AG
![]() Biovertis AG Pharmaceuticals: MajorHealth Technology Biovertis AG operates as a clinical stage pharmaceutical company. It develops small molecule drugs against proprietary microbial antigens. The firm discovers and develops antimicrobial drugs for infections caused by antibiotic-resistant bacterial pathogens. The company was founded by Erich Felber, Uwe von Ahsen, and Alexander Ullrich von Gabain in 2003 and is headquartered in Vienna, Austria. | 6 anni |
Alexis Rideau | M | - |
Morphochem GmbH
![]() Morphochem GmbH Miscellaneous Commercial ServicesCommercial Services Part of Deinove SA, Morphochem GmbH is a German company that engages in research and development of natural sciences, engineering, agricultural sciences, and medicine. The company is based in Munich, Germany. The CEOs are Alexis Rideau, Emmanuel Petiot. The company was founded in 2018. | 4 anni |
Grafico relazionale
Relazione in diverse aziende
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Austria | 4 | 80.00% |
Germania | 1 | 20.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Emmanuel Petiot
- Contatti personali